MEDITE's Tape-Coverslippers can process up to 1,200 microscopic slides per hour compared to up to 400 slides per hour for standard glass coverslippers, a key advantage for high volume labs in the cancer diagnostic segments of cytology and histology.
This undisclosed anatomical pathology company has been granted the exclusive rights to market, sell and distribute MEDITE's coverslipping film as an OEM product in the US and Canada.
The new agreement is expected to be a significant contributor to MEDITE's revenue growth in 2014.
Perrigo to acquire United States rights for Entocort from AstraZeneca
US FDA approves Boehringer Ingelheim's Pradaxa
Phase II clinical trial for potential treatment of androgenetic alopecia completed by Samumed
Life Sciences Partners collaborates on immuno-oncology with Bristol-Myers Squibb
Arsanis initiates first cohort in Phase one clinical trial of ASN100
Impax introduces generic Avodart (Dutasteride) Capsules, 0.5 mg
Mylan unveils generic FazaClo orally disintegrating tablets for treating schizophrenia